Low-volume continuous hemodiafiltration with nafamostat mesilate increases trypsin clearance without decreasing plasma trypsin concentration in severe acute pancreatitis

ASAIO Journal

Volumn 53, Issue 2, 2007, Pages 207-212

  Okita, Yoshio ^a   Okahisa, Toshiya ^a   Sogabe, Masahiro ^a   Suzuki, Masaharu ^a   Ohnishi, Yoshiaki ^a   Ito, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; BLOOD; DIALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW RATE; PATIENT MONITORING;

NAFAMOSTAT MESILATE; PLASMA TRYPSIN CONCENTRATION; SEVERE ACUTE PANCREATITIS; TRYPSIN CLEARANCE;

BIOMEDICAL ENGINEERING;

DIALYSIS FLUID; NAFAMSTAT MESILATE; POLYSULFONE; TRYPSIN;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; DIALYSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME METABOLISM; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; PLASMA CLEARANCE;

ACUTE DISEASE; ADULT; AGED; ANTICOAGULANTS; APACHE; FEMALE; GUANIDINES; HEMODIAFILTRATION; HUMANS; KINETICS; MALE; MIDDLE AGED; PANCREATITIS; RETROSPECTIVE STUDIES; TRYPSIN;

EID: 34247106722     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3180310473     Document Type: Article

References (32)

1. Swaroop VS, Chari ST, Clain JE: Severe acute pancreatitis. JAMA 291: 2865-2868, 2004.
2. Raraty MG, Connor S, Criddle DN, et al: Acute pancreatitis and organ failure: pathophysiology, natural history, and management strategies. Curr Gastroenterol Rep 6: 99-103, 2004.
3. Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21: 522-526, 1993.
4. Hirasawa H, Oda S, Shiga H, Matsuda K: Endotoxin adsorption or hemodiafiltration in the treatment of multiple organ failure. Curr Opin Crit Care 6: 421-425, 2000.
5. Ronco C, Ricci Z, Bellomo R: Importance of increased ultrafiltration volume and impact on mortality: Sepsis and cytokine story and the role for CVVH. Edtna Erca J Suppl 2: 13-18, 2002.
6. Blinzler L, Hausser J, Bodeker H, et al: Conservative treatment of severe necrotizing pancreatitis using early continuous venovenous hemofiltration. Contrib Nephrol 93: 234-236, 1991.
7. Gebhardt C, Bodeker H, Blinzler L, et al: Changes in therapy of severe acute pancreatitis. Chirurg 65: 33-40, 1994.
8. Yekebas EF, Treede H, Knoefel WT, et al: Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg 229: 514-522, 1999.
9. Oda S, Hirasawa H, Shiga H, et al: Continuous hemofiltration/ hemodiafiltration in critical care. Ther Apher 6: 193-198, 2002.
10. Wang H, Li WQ, Zhou W, et al: Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol 9: 2096-2099, 2003.
11. Jiang HL, Xue WJ, Li DQ, et al: Influence of continuous venovenous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 11: 4815-21, 2005.
12. Ohlsson K, Ganrot PO, Laurell CB: In vivo interaction between trypsin and some plasma proteins in relation to tolerance to intravenous infusion of trypsin in dog. Acta Chir Scand 137:113-121, 1971.
13. Brodrick JW, Geokas MC, Largrnan C, et al: Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera. Am J Physiol 237: 478-480, 1979.
14. Lasson A, Ohlsson K: Disseminated intravascular coagulation and antiprotease activity in acute human pancreatitis. Scand J Gastroenterol 21: 35-39, 1986.
15. Ohlsson K, Laurell CB: The disappearance of enzyme-inhibitor complexes from the circulation of man. Clin Sci Mod Med 51:87-92, 1976.
16. Barrett AJ, Starkey PM: The interaction of α2-macroglobulin with proteinases. Biochem J 133: 709-724, 1973.
17. Florholmen J, Jorde R, Olsen RL, et al: Radioimmunoassay of cationic trypsin-like immunoreactivity in man. Scand J Gastroenterol. 19: 613-621, 1984.
18. Akizawa T, Sato M, Kitaoka T, et al: The usefulness of the multi-enzyme inhibitor, nafamostat mesilate, in high bleeding risk hemodialysis. Proc Eur Dial Transplant Assoc 22: 334-338, 1985.
19. Hirasawa H: Severe acute pancreatitis, in Hirasawa H (ed), Acute Blood Purification, Tokyo, Sogo-igaku Co., Ltd., 1994, pp. 115-126 [in Japanese].
20. Ogawa M, Hirota M, Hayakawa T, et al: Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan. Pancreas 25: 325-330, 2002.
21. Iwaki M, Ino Y, Motoyoshi A, et al: Pharmacological studies of FUT-175, nafamostat mesilate V: Effects on the pancreatic enzymes and experimental acute pancreatitis in rats. Jpn J Pharmacol 41: 155-162, 1986.
22. Luiten EJ, Hop WC, Lange JF, Bruining HA: Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 222: 57-65, 1995.
23. Takeda K, Matuno S, Sunamura M, Kakugawa Y: Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotising pancreatitis. The Am J Surg 174: 394-398, 1996.
24. Randoux C, Gillery P, Georges N, et al: Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes. Kidney Int 60: 1571-1577, 2001.
25. van Bommel EF, Hesse CJ, Jutte NH, et al: Cytokine kinetics (TNF-alpha, IL-1 beta, IL-6) during continuous hemofiltration: A laboratory and clinical study. Contrib Nephrol 116: 62-75, 1995.
26. Hitomi Y, Nobuhiko lkari N, Fujii S: Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system. Hemostasis 15: 164-168, 1985.
27. Fujii S, Hitomi Y: New synthetic inhibitors of C1, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim Blophys Acta 661: 342-345, 1981.
28. Kimland M, Russick C, Marks WH, Borgstrom A: Immunoreactive anionic and cationic trypsin in human serum. Clin Chim Acta 184: 31-46, 1989.
29. Kihara Y, Otsuki M: The research committee on intractable disease of the pancreas: Nationwide epidemiological survey of acute pancreatitis in Japan. Pancreas 31: 449, 2005.
30. Larvin M, Alexander DJ, Switala SF, McMahon MJ: Impaired mononuclear phagocyte function in patients with severe acute pancreatitis: Evidence from studies of plasma clearance of trypsin and monocyte phagocytosis. Dig Dis Sci 38: 18-27, 1993.
31. Sander A, Armbruster W, Sander B, et al: Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med 23: 878-884, 1997.
32. Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356: 26-30, 2000.